These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016]. Pár A; Pár G Orv Hetil; 2016 Jun; 157(25):987-94. PubMed ID: 27287838 [TBL] [Abstract][Full Text] [Related]
23. A narrative review on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis versus hepatocellular carcinoma: do you mind? Toman D; Sengul I; Pelikán A; Sengul D; Vavra P; Ihnat P; Roman J; Kayaalp C Rev Assoc Med Bras (1992); 2022; 68(6):871-874. PubMed ID: 35766704 [No Abstract] [Full Text] [Related]
24. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases. Stine JG; Wentworth BJ; Zimmet A; Rinella ME; Loomba R; Caldwell SH; Argo CK Aliment Pharmacol Ther; 2018 Oct; 48(7):696-703. PubMed ID: 30136293 [TBL] [Abstract][Full Text] [Related]
25. Association of nonalcoholic fatty liver disease and liver cancer. Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725 [TBL] [Abstract][Full Text] [Related]
26. Maternal obesity: A severe risk factor in hepatocarcinogenesis? Colnot S; Lechel A J Hepatol; 2020 Sep; 73(3):502-504. PubMed ID: 32593683 [No Abstract] [Full Text] [Related]
27. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Huang DQ; El-Serag HB; Loomba R Nat Rev Gastroenterol Hepatol; 2021 Apr; 18(4):223-238. PubMed ID: 33349658 [TBL] [Abstract][Full Text] [Related]
28. Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study. Simon TG; Roelstraete B; Sharma R; Khalili H; Hagström H; Ludvigsson JF Hepatology; 2021 Nov; 74(5):2410-2423. PubMed ID: 33811766 [TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors. Dongiovanni P; Romeo S; Valenti L World J Gastroenterol; 2014 Sep; 20(36):12945-55. PubMed ID: 25278690 [TBL] [Abstract][Full Text] [Related]
31. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. Jiang CM; Pu CW; Hou YH; Chen Z; Alanazy M; Hebbard L World J Gastroenterol; 2014 Nov; 20(44):16464-73. PubMed ID: 25469014 [TBL] [Abstract][Full Text] [Related]
32. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. Valenti L; Pedica F; Colombo M Dig Liver Dis; 2022 Feb; 54(2):154-163. PubMed ID: 34294580 [TBL] [Abstract][Full Text] [Related]
34. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. Streba LA; Vere CC; Rogoveanu I; Streba CT World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859 [TBL] [Abstract][Full Text] [Related]
35. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. Degasperi E; Colombo M Lancet Gastroenterol Hepatol; 2016 Oct; 1(2):156-164. PubMed ID: 28404072 [TBL] [Abstract][Full Text] [Related]
36. NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), MORE THAN A LIVER DISEASE. Parise ER Arq Gastroenterol; 2019 Sep; 56(3):243-245. PubMed ID: 31633718 [No Abstract] [Full Text] [Related]
37. Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases? Goossens N; Hoshida Y Gastroenterology; 2016 Jun; 150(8):1710-7. PubMed ID: 26784140 [No Abstract] [Full Text] [Related]
38. Polygenic risk score: A promising predictor for hepatocellular carcinoma in the population with non-alcoholic fatty liver disease. Long J; Bian J; Zhao H J Hepatol; 2021 Jun; 74(6):1493-1494. PubMed ID: 33476746 [No Abstract] [Full Text] [Related]